Podcasts about fda

On this episode of Vitality Radio, Jared breaks down the hype around biohacking and shares why foundational health must always come first. He makes the case that biohacking only works when stacked on top of solid foundations. From his decades of experience, he explains how the body's innate intelligence depends on raw materials like vitamins, minerals, enzymes, etc., and why detoxification is essential for removing the roadblocks to healing. Jared outlines his foundational Vital 5 approach along with key detox strategies. You'll also hear how simple, no-cost practices such as sleep, sunlight, grounding, breathwork, and movement can be more impactful than expensive gadgets. While tools like red light therapy, cold plunges, and methylene blue have their place, they cannot replace the basic needs of the human body. If you've wondered whether to dive into the latest health trend or invest in the basics first, this episode will help you understand where to start for long-term results.Products:The Vital 5Back on TractParasite CleanseEndoCleanseLiverVitalityAdditional Information:#432: Your Parasite Cleansing User's Guide#258: Your Magnesium User's Guide#242: The Vital Five How To: Your User's Guide to Filling the Gaps in Your DietVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

In this weekend's episode, three segments from this past week's Washington Journal. First – we chat with Punchbowl News congressional reporter Max Cohen about the prospects for a potential government shutdown in a few short weeks – and the political and policy obstacles to a potential deal. Then: Vaccine expert Dr. Paul Offit discusses his recent removal from the FDA vaccine advisory committee – and his concerns about Secretary Robert F. Kennedy's leadership at HHS. Finally: a conversation with Republican Mike Bost of Illinois - Chair of the Veterans' Affairs Committee-- on this week's 9/11 anniversary, veterans' issues, and the murder of conservative activist Charlie Kirk. Learn more about your ad choices. Visit megaphone.fm/adchoices

Have you ever felt like God left you on the back burner? If you have, you are not alone. On In The Market with Janet Parshall this week one of our favorite writers and teachers was back to share the story Zechariah and Elizabeth from the New Testament and show how God is working even when we don’t see it or His timing doesn’t match with our own. Our guest explains how God removes our fears and weaves His grace in and through even the most prolonged span of waiting. Nobody is exempt from the love of God and that includes even some of the most dyed in the wool atheists in the world today. Our guest shared some amazing stories of just how powerful the gospel message is as she shared the amazing true accounts of former atheist who met the living Christ and despite their deep-seated resistance eventually turned their hearts and lives over to Him. In the midst of this typical week, the nation was shocked by the brazen assassination of popular fighter for conservative values, husband, father and follower of Jesus, Charlie Kirk. Janet and her guest addressed this terrible tragedy and helped us all place our hearts in the right place by encouraging us not to respond in anger and to lift his wife and very young children at this terrible time. Janet’s guest also addressed their scheduled topics related to the end of abortion services at a D.C. location and an update on the FDA and the Covid vaccine. What is it like to be on the ground in the Israel right now? An expert on the intersection of Jewish history and biblical prophecy joined us live from Israel to update us what is happening there as the Gaza war continues. The tragedy earlier this week once again emphasized the need for believers to live with the Bible open and ready to examine everything we see and hear in the news, on feeds and in the culture writ large. Janet and Craig continue their work to show all of us how to be faithful watchmen and watchwomen on the walls surrounding our families, our nation and our world.Become a Parshall Partner: http://moodyradio.org/donateto/inthemarket/partnersSee omnystudio.com/listener for privacy information.

OpenAI and Microsoft say they have ironed out their differences… tentatively. Not officially. I'll explain why that is interesting. With new FDA clearance for the Apple watch are millions of people about to discover they have hypertension? What if AI is less corrupt than humans? And, of course, the Weekend Longreads Suggestions. OpenAI and Microsoft reach tentative deal to revise partnership (Axios) OpenAI Takes Big Steps Toward Its Long-Planned Reorganization (NYTimes) OpenAI & Microsoft Agree to Agree, Tentatively (Spyglass) Apple Watch hypertension alerts feature receives FDA clearance (9to5Mac) Albania appoints AI bot as minister to tackle corruption (Reuters) Weekend Longreads Suggestions: Why is AI struggling to discover new drugs? (Financial Times) Online travel platforms prepare for rise of artificial intelligence ‘agents' (Financial Times) Learn more about your ad choices. Visit megaphone.fm/adchoices

In this solo episode, Lindsey dives into the world of peptide injections, with a focus on the controversial “Wolverine shot” (BPC-157). She explores what peptides are, why they're trending in gyms, wellness clinics, and med spas, and how they're marketed for muscle gain, fat loss, recovery, and anti-aging.Lindsey discusses the science (and lack thereof), FDA concerns, and potential risks like overdosing, contamination, and unregulated use. She closes by reminding listeners that while peptides are intriguing, true health and longevity still come from foundational practices—quality sleep, nutrition, strength training, and meaningful human connection. Listen in to learn more : 01:03 – Why People Use PeptidesClaimed benefits include lean muscle gain, faster recovery, testosterone support, fat loss, and anti-aging. However, the evidence base is thin.01:18 – BPC-157 and Other PeptidesBPC-157: derived from stomach peptides, believed to speed up tissue healing and reduce inflammation.Tesamorelin: studied for HIV-related fat reduction.Sermorelin: targeted for sleep and recovery.CJC-1295 + Ipamorelin: growth hormone–related stacks are popular among bodybuilders.02:28 – Lack of Scientific EvidenceMost data comes from animal studies or small trials, not significant human clinical research.03:55 – FDA ConcernsThe FDA flagged four peptides in 2022; that number jumped to 26 by the end of 2023, showing rapid regulatory scrutiny.04:42 – Anecdotal Use by Doctors and CEOsSome report success with peptides like BPC-157 for injuries, but even they acknowledge the lack of robust science.05:35 – Risks of Overuse and ContaminationOverdosing risks: especially when combining peptides with testosterone, leading to organ enlargement.Contamination/mislabeling: Many peptides sold are unregulated, increasing health risks.06:15 – Back to Basics for LongevityDespite the hype, proven health strategies remain the same: sleep, exercise, protein, reducing sugar, strength training, and social connection.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-lindsey-elmore-show--5952903/support.

In this episode, Dr. Jockers uncovers the surprising truth about Stevia and how it impacts blood sugar and insulin. You'll hear the science behind why this natural sweetener may be better than artificial alternatives—and when it could backfire. This is where you'll start questioning what you thought you knew about “safe” sweeteners.   You'll also learn about the long-standing debate over Stevia and infertility, from tribal practices to animal studies that sparked controversy. Dr. Jockers breaks down why the evidence is far from conclusive, and what the FDA still refuses to say. There's more to this story than the headlines reveal.   And if you've ever felt “off” after using Stevia, you'll find out why. Hidden sensitivities, especially in those allergic to ragweed, can completely flip its effects. Understanding how your body personally responds could be the missing key to deciding if Stevia is really right for you.     In This Episode:  00:00 Introduction: Does Stevia Cause Infertility? 00:23 Podcast Welcome and Overview 02:51 Deep Dive: The Truth About Stevia 03:59 Stevia and Blood Sugar 05:08 Stevia's Health Benefits and Allergies 06:58 Controversy: Stevia and Infertility 13:26 Further Studies on Stevia and Infertility 16:09 Conclusion: Stevia's Impact on Health 18:47 Final Thoughts and Farewell   Struggling with stress, low energy, or poor sleep? Magnesium Breakthrough is designed to help calm your mind, enhance focus, and improve sleep quality with all seven forms of magnesium. Take advantage of an exclusive offer by visiting bioptimizers.com/jockers and using the promo code Jockers at checkout to save 10%. Don't forget to subscribe for even more discounts and free gifts with your monthly supply! If you're serious about reducing your toxic load, I highly recommend upgrading to the P600 ceramic cookware. It's 100% free from Teflon, PFAS, and plastic coatings, ensuring a non-toxic cooking experience. Right now, you can get it for 50% off, plus an extra 20% off with the code SAFE20 at checkout! Don't miss this limited-time offer—head to chefsfoundry.com/jockers to claim your discount today! Support your skin from the inside out with Clearstem, the acne brand that connects internal and external skincare without pore-clogging ingredients. Pair their best-selling Mind Body Skin hormonal acne supplement with Clearstem's clinically effective topicals for results that last. Get 15% off your order today at clearstem.com/drjockers using code DRJOCKERS at checkout.   “Stevia can improve blood sugar control—yet for a small group, it may raise inflammation and fertility risks.”  ~ Dr. Jockers     Subscribe to the podcast on: Apple Podcast Stitcher Spotify PodBean TuneIn Radio     Resources: Use code JOCKERS at bioptimizers.com/jockers to save 10% Use code Safe20 at chefsfoundry.com/jockers Get 15% off your order today at clearstem.com/drjockers using code DRJOCKERS     Connect with Dr. Jockers: Instagram – https://www.instagram.com/drjockers/ Facebook – https://www.facebook.com/DrDavidJockers YouTube – https://www.youtube.com/user/djockers Website – https://drjockers.com/ If you are interested in being a guest on the show, we would love to hear from you! Please contact us here! - https://drjockers.com/join-us-dr-jockers-functional-nutrition-podcast/ 

Health care executive Max Rollwage discusses his article "The promise and perils of AI in health care: Why we need better testing standards." Max highlights the risks of relying on AI systems that are evaluated through artificial scenarios or even other AI models, emphasizing the dangers of circular validation in high-stakes environments like emergency care. He discusses why true readiness requires real-world clinical trials, expert human evaluation, and impact studies on patient outcomes. Max also points to the role of regulators like the FDA and AI Safety Institutes in setting higher standards, and he offers practical insights on how the medical community and technology developers can ensure safe and effective AI deployment. Listeners will come away with a clearer understanding of both the promise and the perils of AI in medicine, and what it will take to responsibly bring these tools to the bedside. Our presenting sponsor is Microsoft Dragon Copilot. Want to streamline your clinical documentation and take advantage of customizations that put you in control? What about the ability to surface information right at the point of care or automate tasks with just a click? Now, you can. Microsoft Dragon Copilot, your AI assistant for clinical workflow, is transforming how clinicians work. Offering an extensible AI workspace and a single, integrated platform, Dragon Copilot can help you unlock new levels of efficiency. Plus, it's backed by a proven track record and decades of clinical expertise, and it's part of Microsoft Cloud for Healthcare, built on a foundation of trust. Ease your administrative burdens and stay focused on what matters most with Dragon Copilot, your AI assistant for clinical workflow. VISIT SPONSOR → https://aka.ms/kevinmd SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: kids' A1C and tech access correlation, first generic GLP-1 for weight loss approved, Metformin cuts long covid risk, Tandem Diabetes & Eversense updates, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Accessibility to modern diabetes technology directly correlates with A1c among children with type 1 diabetes globally. Big, cross-sectional study, conducted in 81 pediatric diabetes centers in 56 countries, found that a greater extent of reimbursement for continuous glucose monitoring (CGM), insulin pumps, glucose meters, and insulin was associated with lower A1c levels. Partha S. Kar, MD, Type 1 Diabetes & Technology lead of the National Health Service England, told Medscape Medical News, “As is now being shown in countries such as UK with widespread uptake of technology, there is now population-wide shift in A1c not seen before.”   He added, “If policymakers are serious about bringing A1c at a population level to sub-7.5% - 8% levels, then without technology it would be incredibly difficult to achieve, in my experience and opinion. Leaving the median A1c of a population at above 7.5%-8% goes with complications so that's a decision regarding investment many will have to make in the near future.”   In an accompanying editorial, Elizabeth R. Seaquist, MD, professor of diabetes, endocrinology, and metabolism and co-director of the Institute for Diabetes, Obesity, and Metabolism at the University of Minnesota, Minneapolis, called it “striking” that access to technology in and of itself was associated with improved glycemic control, given that multidisciplinary team care is also needed to provide education and behavioral or psychological support.     https://www.medscape.com/viewarticle/diabetes-tech-access-linked-a1c-kids-t1d-globally-2025a1000nn6 XX A man with type 1 in Illinois has received the first FDA-approved islet-cell replacement treatment, Lantidra, and  he is now producing his own insulin. The treatment works by restoring the body's beta cells, potentially eliminating the need for insulin injections.   The FDA approved Lantidra (donislecel) in 2023. Lantidra uses donor cells and requires lifelong immunosuppressive drugs.     Lantidra is only available at University of Illinois Chicago Health. Other universities, such as the University of Pennsylvania, continue to do islet cell transplants as part of clinical trials. Early data has shown that a majority of participants in the Lantidra clinical study were able to achieve some level of insulin independence, but it's unclear whether the benefits of donislecel outweigh the treatment's safety risks. Nearly 87 percent of participants reported infection-related adverse events, and post-operation complications included liver lacerations, bruising of the liver (hepatic hematoma), and anemia. One patient died of multi-organ failure from sepsis, which Lantidra maker CellTrans stated was “probably related” to the use of either immunosuppression or study drugs.   In addition, some industry leaders have raised the question of whether it's ethical to commercialize the use of deceased donor islet cells. https://diatribe.org/diabetes-research/first-fda-approved-islet-cell-transplant-performed?utm_campaign=feed&utm_medium=social&utm_source=later   XX Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk's injected Saxenda (liraglutide).   The compound, which is a GLP-1 forerunner of Novo's semaglutide products Ozempic and Wegovy, has been approved by the FDA to treat adults with obesity and those who are overweight and have weight-related medical problems.     Saxenda also is endorsed for pediatric patients ages 12 through 17 who are obese and weigh at least 60 kg (132 pounds). The treatment is for both triggering and maintaining weight loss. Saxenda is not the first GLP-1 drug that is available as a generic. In June of last year, Teva also was the first company to launch a knockoff version of Novo's Victoza, which is the same compound as Saxenda but has been approved only for patients with Type 2 diabetes. Sales of the branded versions of both Victoza and Saxenda have declined significantly in recent years as demand for Novo's semaglutide and Eli Lilly's tirzepatide products have skyrocketed. In addition, marketers of compounded products have been aggressively competing for market share in the GLP-1 space. https://www.fiercepharma.com/pharma/saxenda-knockoff-teva-launches-first-generic-glp-1-obesity   XX Metformin could cut the risk of Long COVID by 64% in overweight or obese adults who started the drug within 90 days of infection. The large observational study, published in Clinical Infectious Diseases, analysed health records of over 624,000 UK adults with COVID-19 between March 2020 and July 2023. Among these, nearly 3,000 patients who began metformin treatment soon after diagnosis were tracked for a year. Compared to non-users, their likelihood of developing Long COVID, defined as persistent symptoms 90 days or more after infection, was dramatically lower. https://www.ndtv.com/health/metformin-cuts-risk-of-long-covid-by-64-why-the-diabetes-pill-is-not-for-everyone-9242332 XX Forty-four percent of people age 15 and older living with diabetes are undiagnosed, so they don't know they have it, according to data analysis published Monday in the journal The Lancet Diabetes & Endocrinology. The study looked at data from 204 countries and territories from 2000 to 2023 in a systematic review of published literature and surveys. “The majority of people with diabetes that we report on in the study have type 2 diabetes,” said Lauryn Stafford , the lead author of the study.   “We found that 56% of people with diabetes are aware that they have the condition,” said Stafford, a researcher for the Institute for Health Metrics and Evaluation. “Globally, there's a lot of variation geographically, and also by age. So, generally, higher-income countries were doing better at diagnosing people than low- and middle-income countries.” People under 35 years were much less likely to be diagnosed if they had diabetes than people in middle age or older. Just “20% of young adults with diabetes were aware of their condition,” Stafford said. https://www.cnn.com/2025/09/08/health/diabetes-undiagnosed-half-of-americans-wellness XX A team of Hong Kong scientists is developing an injectable treatment that could potentially improve blood flow in diabetes patients' feet, in the hopes that it will reduce the need for amputation by rebuilding tissue in the arteries.   They also hope to apply the treatment to peripheral artery disease or PAD, a condition caused by the build-up of fatty deposits in arteries that affect blood circulation in the feet. “Traditional treatments for people suffering from poor blood flow in their legs are stent implantation or bypass surgery, which is invasive,” said Wong, who is also the co-founder of a biotechnology company called NutrigeneAI. He said it was his dream to turn research in the academic field into actual clinical treatments. But he added that the team still needed three to four years for further research on the treatment.   https://www.scmp.com/news/hong-kong/health-environment/article/3324671/hong-kong-scientists-developing-new-blood-flow-treatment-aid-diabetes-patients XX   Tandem Diabetes announces Health Canada authorization for distribution of the Tandem t:slim mobile application for Android and iPhone users. The Tandem t:slim mobile app allows users to deliver a bolus from their compatible smartphone, and to wirelessly upload their pump data to the cloud-based Tandem Source platform.1 The app is expected to be available later this year.   The Tandem t:slim mobile app will be available for compatible smartphones in the Apple App Store and Google Play store later in 2025. Once available, Tandem will email eligible customers with instructions on how to download and use the app.  https://www.businesswire.com/news/home/20250904665715/en/Tandem-tslim-Mobile-App-Now-Authorized-by-Health-Canada-for-iPhone-and-Android-Phones   XX Some changes to how the Eversense CGM will be rolled out.. right now it's being distributed by Ascensia Diabetes Care.  Senseonics will take back commercial control of the year long implantable CGM on January 1 in the US and expanding worldwide throughout 2026. The change was a mutual decision, according to the two companies, which said they have signed a memorandum of understanding before a definitive agreement is hammered out by the end of the year. To get started, Senseonics is also set to acquire members of Ascensia's commercial staff—including its CGM president, Brian Hansen, who is slated to become Senseonics' new chief commercial officer. https://www.fiercebiotech.com/medtech/senseonics-retake-eversense-cgm-commercial-control-ascensia-diabetes-care XX Utrecht-based medical device company ViCentra has closed an $85 million Series D round of funding led by Innovation Industries, along with existing investors Partners in Equity and Invest-NL. The round also drew support from EQT Life Sciences and Health Innovations.   The recent capital injection will be used to expand ViCentra's manufacturing capabilities, support regulatory approvals, and strengthen commercial rollout across Europe.   The funds will also be used to launch the next-generation Kaleido 2 patch pump in Europe and prepare for entry into the U.S. market.   The global insulin delivery market is growing quickly due to the increasing number of diabetes cases and demand for effective and user-friendly solutions. The market for insulin pumps is projected to exceed $14 billion by 2034. Patch pumps are the fastest-growing segment, signalling a trend toward compact and wearable devices. And here's where ViCentra is positioned to meet this need, offering a user-friendly, sleek design-led alternative to traditional systems.   Kaleido: design-led insulin delivery Kaleido is the smallest and lightest insulin patch pump developed as a lifestyle product with a particular focus on usability and personalisation.   Designed to feel more like personal technology than a traditional medical device, Kaleido features premium materials, and users can select their own favourite aluminium shells from a range of ten preset colour options.   It integrates with Diabeloop's hybrid closed-loop algorithms (DBLG1 and DBLG2) and is compatible with Dexcom CGM sensors, positioning it within the next generation of automated insulin delivery systems.   “Kaleido is a true disruptor — small, discreet, featherlight, and beautifully designed. It empowers people with diabetes by offering a more personal and distinctive choice in both function and style. Built with empathy and precision, it honours those who live with diabetes every day. With this funding, we can now meet surging European demand and fast-track our entry into the U.S. market. This is a pivotal moment — for ViCentra, and for the community we serve,” said Tom Arnold, Chief Executive Officer at ViCentra.   Improving the quality of life for diabetic patients ViCentra, led by Tom Arnold, is on a mission to improve the lives of those with diabetes.   The company reported that demand for Kaleido in Germany, France, and the Netherlands has already exceeded initial expectations.   ViCentra will present updates on Kaleido at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD), taking place September 15–19, 2025, in Vienna.   The company plans to engage with clinicians, investors, and strategic partners to further its role in the evolving diabetes care landscape.   “ViCentra is redefining insulin pump therapy with a platform that truly centres the user experience – combining clinical performance with design simplicity and wearability,” commented Caaj Greebe, Partner at Innovation Industries. “At Innovation Industries, we invest in pioneering companies that blend world-class technology with clear commercial potential. ViCentra exemplifies this by delivering a next-generation system addressing the urgent need for better treatment options in diabetes care. We're proud to lead this investment round and partner with Tom and the team as they deepen and expand their presence in Europe and prepare for U.S. entry.”   https://techfundingnews.com/dutch-vicentra-secures-85m-to-bring-insulin-patch-pump-to-more-markets/ XX Luna Diabetes announces they've raised more than 23-million dollars in early venture capital to help continue clinical trials and build out its capacity. This is the company that wants to offer a night time only, tiny, temporary insulin pump – to supplement insulin pen use. According to the company, more than 80% of the improvements in blood sugar from automated insulin delivery systems occur while the user is sleeping. Luna launched a pivotal trial late last year. https://www.fiercebiotech.com/medtech/nighttime-insulin-patch-pump-maker-luna-diabetes-raises-236m   XX Following 15 days and 150 fingerpricks, they're here. The results of the “9 sensor samba“. And what a set of a results…   Well maybe that's overplaying it a little.   Let's just say that the outcome of this n=1 experiment wasn't quite what I expected. One of the established players came out much worse than expected, while a newcomer did a lot better.   Let's dig in, and take a look at the variation. https://www.diabettech.com/cgm/the-nine-sensor-samba-results-revealed/   XX Hard work and perseverance define ranch life, but one man in eastern Montana takes it to another level. At 90, he's still living independently on the ranch he built from the ground up. Even more remarkable? He's a type 1 diabetic.   Bob Delp still begins each day just like he did decades ago, waking up on his ranch near Richey, Montana.   “I always thought if I could ever get a ranch and run a hundred cows, that's what I wanted to do from the time I was a kid,” said Delp.   He made that dream real, the hard way; after coming home from the army, he taught school, hayed for seven cents a bale and saved every cent he could.     “I worked at it real hard because I always felt like it was going to be part of getting me to that ranch that I always wanted,” said Delp.   He did it all while managing type 1 diabetes, a diagnosis that came with few answers and little hope back in the 1950s.   “The doctors tell me being a type 1 diabetic for 66 years isn't supposed to happen. Back then, it was a real challenge,” added Delp.   Statistically, it's almost unheard of. Fewer than 90 people in the world have lived more than 70 years with type 1 diabetes.     Bob credits his late wife, Donna, for helping him beat the odds.   “She has been key in that I always ate on time.”   They've faced their share of storms, both in health and out on the land. Not long after moving to Richey, a heavy snowstorm nearly tore everything apart just after they'd stepped out for dinner.   “If Donna hadn't said it was time to eat, we wouldn't have made it out of there. I guess that's one time that made me happy to have diabetes. And I think that saved us,” said Delp.     Now, he still checks his blood sugar daily but trusts his hands more than high-tech insulin pumps.   “I'm not satisfied with the sensors they have today. I just don't think they're accurate.”   To many, Bob's survival is extraordinary. To him, it's luck.   “The genes are there already, I can't change that so I guess I would have to say just lots of good luck,” said Delp.     And through it all, optimism has been his compass.   “You might fumble the ball, but if you're determined to be a winner, you'll recover that fumble someday,” said Delp.   He still welds nearly every day. Not because he has to, but because it keeps him going.   “As long as I keep doing something like this, I will not be in the nursing home,” said Delp.   https://www.kfyrtv.com/2025/08/09/against-all-odds-montana-man-thrives-with-type-1-diabetes-90/ XX Today, Dexcom is building on this belief and breaking new ground with the launch of its first open call across the U.S. and Canada in search of the next diabetes advocates—giving people with all types of diabetes a once-in-a-lifetime opportunity to raise awareness and share their voice on a global scale in the company's World Diabetes Day campaign (Nov. 14) and beyond.  Who is eligible?: Anyone age 2+ living with all types of diabetes or prediabetes can be nominated by themselves or by someone who knows them. Selected candidates will embody strength, advocacy and pride in living with diabetes or prediabetes. Where and how can I nominate myself or someone I know?: Visit Dexcom.com/WorldDiabetesDay When is the deadline to submit a nomination?: Nominations are open from September 10 through September 19 at 12pm PT. What will the selected candidates experience?:   An invite to participate in a World Diabetes Day photoshoot in Los Angeles to have their unique story featured in Dexcom's World Diabetes Day campaign The ongoing opportunity to attend events, connect with community, and raise diabetes awareness around the world XX The European Association for the Study of Diabetes (EASD) 2025 Annual Meeting will feature major clinical trial results in type 2 diabetes (T2D), type 1 diabetes (T1D), obesity, several new clinical practice guidelines, and much more. The 61st annual EASD meeting will take place on September 15-19, 2025, in Vienna, Austria.   

EP. 230: Grab my FREE 4 Part Video Series: GLP1s Uncovered: https://bit.ly/GLP1uncovered In this solo episode, I'm sharing insights on HRT, hormone replacement therapy in the online space, peptides, and how the wellness industry has shifted over the years. I cover everything from minimal effective dose to personalized medicine, bioidentical hormones, FDA guidance, peptide stacking, and the realities of HRT for menopause and hormone intolerance. I also share my perspective on women's health, dosing strategies, and what to do when HRT isn't working, plus how to spot influencer scams in the wellness world. Topics Discussed: → How do personalized medicine strategies improve metabolic health? → What are the benefits of bioidentical hormones for menopause? → How to spot wellness influencer scams online? Sponsored By: → Puori | Go to Puori.com/drtyna and use code DRTYNA to get 20% off → Qualia | Go to qualialife.com/DRTYNA for up to 50% off your purchase and use code DRTYNA for an additional 15% → Nutrisense | Head over to nutrisense.io/drtyna and use the code TYNA to save 33% on your Nutrisense Program. → BIOptimizers | For 15% off go to bioptimizers.com/drtyna and use promo code DRTYNA → LMNT | Get a free 8-count Sample Pack of LMNT's most popular drink mix flavors with any purchase at drinklmnt.com/drtyna. Find your favorite LMNT flavor, or share with a friend. → Dr Tyna's Brain spark | Go to store.drtyna.com/products/brainspark and use code BRAINSPARK10 for 10%  On This Episode We Cover:  → 00:00:00 - Introduction  → 00:04:15 - Minimal effective dose → 00:07:53 - Personalized medicine → 00:11:47 - Finding the right doctor → 00:13:40 - Social media misinformation → 00:15:45 - Metabolic health → 00:18:21 - HRT influencers & telemedicine → 00:21:34 - Online chiropractors → 00:24:44 - Bioidentical hormones → 00:27:26 - FDA & peptide safety → 00:29:10 - Research peptides → 00:33:28 - Peptide stacking → 00:36:35 - HRT & menopause → 00:39:26 - Hormone intolerance → 00:43:10 - HRT dosing → 00:45:11 - Women's health concerns → 00:48:15 - When HRT doesn't work → 00:52:56 - Influencer scams Show Links:  → Find A Doc  → Metabolic Revamp Toolkit  Further Listening:  → EP. 221 | The GLP-1 Microdosing Lie: It's NOT a Weight Loss Strategy | Solo → EP. 225 | The Peptide Craze: What Influencers Don't Know & Aren't Telling You → EP. 204 | Fake Credentials & Medical Misinformation: What You Need to Know | Solo Disclaimer: Information provided in this podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional, or any information contained on or in any product. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before taking any medication or nutritional, herbal or other supplement, or using any treatment for a health problem. Information provided in this blog/podcast and the use of any products or services related to this podcast by you does not create a doctor-patient relationship between you and Dr. Tyna Moore. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease.

200 episodes ago, I had a simple dream: put life-changing information on a platform for free, and watch humanity transform. Today, that vision has created the world's leading health and wellness podcast, featuring conversations with RFK Jr. outlining his $1.9 trillion plan to end FDA corruption, Dana White sharing how his life was saved through basic keto principles and methylated vitamins, and even being invited to the White House with Max Lugavere to continue fighting for health advocacies. The movement to Make America Healthy Again (MAHA) isn't just a slogan, it's a science-backed revolution; and we, at The Ultimate Human, continue to fight for this mission! Join the Ultimate Human VIP community for Gary Brecka's proven wellness protocols!: https://bit.ly/4ai0Xwg Thank you to our partners H2TABS: “ULTIMATE10” FOR 10% OFF: https://bit.ly/4hMNdgg BODYHEALTH: “ULTIMATE20” FOR 20% OFF: http://bit.ly/4e5IjsV BAJA GOLD: "ULTIMATE10" FOR 10% OFF: https://bit.ly/3WSBqUa EIGHT SLEEP: SAVE $350 ON THE POD 4 ULTRA WITH CODE “GARY”: https://bit.ly/3WkLd6E COLD LIFE: THE ULTIMATE HUMAN PLUNGE: https://bit.ly/4eULUKp WHOOP: JOIN AND GET 1 FREE MONTH!: https://bit.ly/3VQ0nzW MASA CHIPS: 20% OFF FIRST ORDER: https://bit.ly/40LVY4y VANDY: “ULTIMATE20” FOR 20% OFF: https://bit.ly/49Qr7WE AION: “ULTIMATE10” FOR 10% OFF: https://bit.ly/4h6KHAD A-GAME: “ULTIMATE15” FOR 15% OFF: http://bit.ly/4kek1ij CARAWAY: “ULTIMATE” FOR 10% OFF: https://bit.ly/3Q1VmkC HEALF: 10% OFF YOUR ORDER: https://bit.ly/41HJg6S BIOPTIMIZERS: “ULTIMATE” FOR 15% OFF: https://bit.ly/4inFfd7 RHO NUTRITION: “ULTIMATE15” FOR 15% OFF: https://bit.ly/44fFza0 GOPUFF: GET YOUR FAVORITE SNACK!: https://bit.ly/4obIFDC GENETIC TEST: ⁠https://bit.ly/3Yg1Uk9 Watch  the “Ultimate Human Podcast” every Tuesday & Thursday at 9AM EST: YouTube: https://bit.ly/3RPQYX8 Podcasts: https://bit.ly/3RQftU0 Connect with Gary Brecka Instagram: https://bit.ly/3RPpnFs TikTok: https://bit.ly/4coJ8fo X: https://bit.ly/3Opc8tf Facebook: https://bit.ly/464VA1H LinkedIn: https://bit.ly/4hH7Ri2 Website: https://bit.ly/4eLDbdU Merch: https://bit.ly/4aBpOM1 Newsletter: https://bit.ly/47ejrws Ask Gary: https://bit.ly/3PEAJuG Timestamps: 00:00 Intro of Show 01:23 Best of The Ultimate Human Podcast 02:17 Corruption behind Big Pharma with US Sec. Robert Kennedy, Jr. 04:06 Steve Harvey's Health Journey 5:45 Dr. Carrie Carda on female health 06:53 Childhood Obesity with Dr. Mark Hyman  08:45 Overcoming Lyme Disease with Dr. Christina Rahm 09:50 Health Advocacies and Movements at the White House with Max Lugavere 12:28 Revealing the Real Intention of American Food Supply with Courtney Swan  13:14 Dave Asprey on Toxic Mold and Mitochondria 15:14 Joe Rogan's Journey from Fear Factor to Podcasting 16:50 Dana White's Health Journey with Gary Brecka 18:32 The Real Cause of Heart Disease with Dr. Aseem 19:52 The Number 1 Way to Beat Addiction with Divinia Taylor 20:22 Paul Saladino on What Your Gut is Telling You 20:43 Mario Lopez and His Secret of Staying Young 21:07 Prioritizing Health for Better Business with Daymond John 22:21 Patrick Bet-David on Living an Authentic Life 23:03 The Ultimate Human's Mission Continues The Ultimate Human with Gary Brecka Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The Content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. Learn more about your ad choices. Visit megaphone.fm/adchoices

Presented by Happy Dad Hard Seltzer. Find Happy Dad near you http://happydad.com/find (21+ only). Video is available on https://youtube.com/@onenightwithsteiny/videos. Follow Steiny on Instagram http://instagram.com/steiny. Get harder, longer-lasting erections with Ro Sparks: $15 off first order of medication to get hard at http://ro.co/steiny Compounded drugs are permitted to be prescribed under federal law but are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review by the FDA. For full safety information, go to http://ro.co/safety Part of the Shots Podcast Network (shots.com). You can listen to the audio version of this podcast on Spotify, Apple Podcasts & anywhere you listen. Learn more about your ad choices. Visit megaphone.fm/adchoices

What are your thoughts on the perfect amino?  I want to support my strength training, aerobics, yoga and pilatesWhen I take protein powders and creatine, urination comes to a halt for several hours.  Is this normal?Are drip coffee makers made from plastic bad for your health?I have a 50% chance of thyroid cancer based on molecular testing.  Must I have it removed?I'm taking 10 mg. DHEA, based on my practitioner's recommendation 10 years ago. Is it safe to continue?Do you recommend ivermectin or fenbendazole?

ANH fighting for free speech on the true benefits of supplementsWhat can I do about Morton's Neuroma aside from surgery?Which form of magnesium do you recommend for mitral valve prolapse with regurgitation?

Join Jay Gunkelman, QEEGD (the man who has analyzed over 500,000 brain scans), Dr. Mari Swingle, and host Pete Jansons for another engaging NeuroNoodle Neurofeedback Podcast episode with special guest Dr. Tiff Thompson (clinical neuroscientist, educator, and CEO of NeuroField Neurotherapy), covering neuroscience, psychology, mental health, and brain training.✅ Topic 1 Explained: Dr. Tiff Thompson's journey from wind energy to neuroscience—building NeuroField Neurotherapy in Santa Barbara and launching The School of Neurotherapy.✅ Topic 2 Deep Dive: Vagus nerve stimulation—who it helps, how it's measured (HRV, tragus stimulation), and practical cautions.✅ Topic 3 Insights: Standards, certifications, and the “circular firing squad”—BCIA/QEEG-D, databases, FDA, and why governance could accelerate adoption.✅ Additional Topics:

This episode is sponsored by BONESUPPORT™, makers of CERAMENT® G – an FDA authorized, antibiotic-eluting bone void filler. For more information, visit https://www.bonesupport.com/en-us/products/cerament-g/ Scott M. Sandilands, DO moderates a conversation about the uses of CERAMENT G in open fractures and fracture-related infections with Peter Everson, MD and Augustine Saiz, MD. The conversation highlights the 2-CAN technique for IM nailing, where CERAMENT G is delivered alongside intramedullary fixation to provide both structural stability and targeted local antibiotic delivery. Interested in staying in touch? Follow BONESUPPORT on LinkedIn https://www.linkedin.com/company/bonesupport-ab/ References discussed in this episode: ·       McNally, M. A., et al. “Mid- to long-term results of single-stage surgery for patients with chronic osteomyelitis using a bioabsorbable gentamicin-loaded ceramic carrier.” Bone Joint J. 2022; 104-B(9): 1095-1100. ·       Henry, L., et al. “Long-Term Follow-Up of Open Gustilo-Anderson IIIB Fractures Treated With an Adjuvant Local Antibiotic Hydroxyapatite Bio-Composite.” Cureus. 2023; 15(5). For additional educational resources visit OTA.org  

It seems there are news stories every week about the accelerating pace of innovation in gene therapy, but only about 50 therapies have been approved so far by the US Food and Drug Administration. Our guest today, Dr. Bobby Gaspar, leads a UK-based biotech company, Orchard Therapeutics, that developed one of those treatments using gene-modified stem cells in your blood that self-renew, so a single administration can give you potentially a lifelong effect. “Our approach is about correcting those hematopoietic stem cells and allowing them to give rise to cells that can then correct the disease,” explains Dr. Gaspar.  The therapy in focus is lenmeldy, the first approved treatment for metachromatic leukodystrophy, also known as MLD, a devastating inherited disorder that affects roughly 600 children worldwide. But Dr. Gaspar is optimistic that learnings from Orchard's work on MLD could be useful in treating much more common disorders including frontotemporal dementia, Crohn's disease and others. This highly informative conversation with host Lindsey Smith also explores the importance of newborn screening, community collaboration in advancing clinical trials for rare diseases, and a future in which each gene therapy will be used as a tool for specific applications.  “There will be many gene therapies available, some of which will become the standard of care for certain diseases, but it won't be for every disease.”Mentioned in this episode:Orchard Therapeutics If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/raisethelinepodcast

In this episode of The Tech Leader's Playbook, Avetis Antaplyan sits down with Susan Ruediger, Founder and Chief Mission Officer of the CMT Research Foundation (CMTRF), and Laura MacNeill, the organization's CEO. Together, they explore how patient-led research is revolutionizing drug development and catalyzing billion-dollar outcomes. Susan shares the remarkable story of CMTRF's $128,000 seed investment in DTX Pharma that led to a $1 billion Novartis acquisition — a masterclass in strategic risk-taking and venture philanthropy. Laura explains how CMTRF's unique “go-out-of-business” mission drives urgency, focus, and impact, while also inspiring other nonprofits to adopt similar models. The conversation dives deep into storytelling's role in galvanizing donors, the importance of milestones and reinvestment, and how rare disease foundations can unlock breakthroughs for broader neurodegenerative diseases like ALS, Parkinson's, and Alzheimer's. Whether you're a biotech leader, investor, or nonprofit executive, this episode offers actionable lessons on focus, partnerships, and creating outsized impact with limited resources.TakeawaysPatient-led research can de-risk and accelerate drug development.$128K seed funding led to a $1B Novartis acquisition.CMTRF uses a venture-philanthropy model with milestone-based funding.Mission: fund treatments, find a cure, close the foundation.Storytelling drives awareness, donations, and partnerships.Early investments keep promising science alive.Biotech partnerships share risk and leverage expertise.Novartis validated CMT as a major market opportunity.Rare disease focus offers faster FDA pathways.Staying laser-focused means saying no to distractions.Chapters00:00 Intro & Guest Welcome01:20 From Grassroots Donations to Billion-Dollar Deals02:30 Understanding CMT and Its Impact05:00 Finding the Right Delivery Vehicle for Drugs07:40 The $128K Bet That Changed Everything09:50 Other Success Stories & Market Signaling13:00 The Venture-Philanthropy Model Explained16:30 The Power of Milestones and Flexibility18:45 Reinvestment and Sustainable Funding21:30 Role of Storytelling and Strategy in Movement Building26:10 Velocity Campaign & Raising $20M27:25 Why Biotechs Care About Rare Diseases31:50 CMT as a Gateway Indication for Neurodegenerative Disease33:30 Staying Focused and Saying No38:30 The Drug Development Lifecycle and Staying Mission-Aligned42:10 How to Get Involved and Follow CMTRF's Work45:10 Personal & Business Advice for Leaders48:30 Favorite Books and Final Thoughts52:00 Closing Remarks and Call to ActionSusan Ruediger's Social Media Links:https://www.linkedin.com/in/susan-ruediger/Laura MacNeill's Social Media Links:https://www.linkedin.com/in/laura-macneill-m-b-a-97633732/CMT Research Foundation's Website:https://cmtrf.org/Resources and Links:https://www.hireclout.comhttps://www.podcast.hireclout.comhttps://www.linkedin.com/in/hirefasthireright

The FDA has endorsed vibration-controlled transient elastography as a surrogate endpoint for MASH trials, marking the first non-invasive alternative to liver biopsy. A Japanese cohort study linked breakfast skipping and late dinners to higher fracture risk, with combined habits raising risk by nearly 25%. Finally, a global meta-analysis suggests shingles vaccination reduces major cardiovascular events by ~16–18%, though most evidence is observational.

In our last two episodes we discussed the impact of U.S. policy shifts on global FDA-regulated products supply chain and shared industry perspectives on global supply chain disruptions. On today's episode, we unpack the sweeping tax reforms introduced by the One Big Beautiful Bill Act signed into law on July 4, 2025. With major changes to R&D expensing, international tax regimes, and incentives for domestic manufacturing, the bill is poised to reshape the global pharmaceutical supply chain. We explore how these provisions affect multinational pharma companies' supply chain strategies.Winston Kirton – wkirton@bakerlaw.com Brian Davis – bdavis@bakerlaw.com

Episode 2695 - Vinnie Tortorich and Chris Shaffer discuss a listener's bizarre health report, how labeling lies matter, and not limiting your goals. https://vinnietortorich.com/2025/09/labeling-lies-matter-episode-2695 PLEASE SUPPORT OUR SPONSORS   YOU CAN WATCH THIS EPISODE ON YOUTUBE - Labeling Lies Matter Scott, a listener, was in horrible shape, but a family member called CPS services because they were worried for his well-being. (2:00) They thought he was going through a mental health challenge because he was eating healthfully and trying to become active. Protective Services observed him for 3 months to ensure nothing was wrong. But now, the family is on board. (7:00) The ridiculous viewpoint appears to be that a person must be mentally unstable for trying to eat low-carb and for eating more healthfully. (11:00) Vinnie's “Dirty Keto” documentary was prophetic. Companies had started marketing products labeled “keto” that were still junk. (17:00) Lawsuits are popping up based on claims made on certain keto product labels. LMNT electrolytes is being called out for the use of things like maltodextrin hidden under the canopy of “natural flavors.” (21:00) It's interesting to see people start to push back against Big Food. (27:00) “Keto Certified” is not something the FDA actually does. Washington, D.C, is one of the most expensive places to live in the United States, and it's not a coincidence that it's filled with luxury shopping areas. (37:00) Back to the RFK fitness challenge video (link below for reference). (43:00) Some view it as unfeasible for most people, so they shouldn't even try. (45:00) The moral of the story is to try something new and set goals. Get started at the level you can begin now, and set incremental goals. The goal isn't the problem—the problem is the limited mindset. (54:00) If you are interested in the NSNG® VIP group, it will be reopening soon. But you can get on the wait list - More News If you are interested in the NSNG® VIP group, it will be reopening soon. But you can get on the wait list - Don't forget to check out Serena Scott Thomas on Days of Our Lives on the Peacock channel.  “Dirty Keto” is available on Amazon! You can purchase or rent it . Make sure you watch, rate, and review it! Eat Happy Italian, Anna's next cookbook, is available!  You can go to  You can order it from .  Anna's recipes are in her cookbooks, website, and Substack–they will spice up your day!  Don't forget you can invest in Anna's Eat Happy Kitchen through StartEngine.  Details are at Eat Happy Kitchen.    PURCHASE  DIRTY KETO (2024) The documentary launched in August 2024! Order it TODAY! This is Vinnie's fourth documentary in just over five years. Visit my new Documentaries HQ to find my films everywhere:  Then, please share my fact-based, health-focused documentary series with your friends and family. Additionally, the more views, the better it ranks, so please watch it again with a new friend! REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! PURCHASE BEYOND IMPOSSIBLE (2022) Visit my new Documentaries HQ to find my films everywhere:  REVIEWS: Please submit your REVIEW after you watch my films. Your positive REVIEW does matter! FAT: A DOCUMENTARY 2 (2021) Visit my new Documentaries HQ to find my films everywhere:  FAT: A DOCUMENTARY (2019) Visit my new Documentaries HQ to find my films everywhere: 

This hour, we take a look at some of the stories making headlines before talking with Dr. Michael New about the valiant efforts of a pro-life group working to stop abortions in the nation’s Capital. We then talk with Dr. David Gortler about the new guidelines for COVD vaccinations and the changes taking place at the FDA.Become a Parshall Partner: http://moodyradio.org/donateto/inthemarket/partnersSee omnystudio.com/listener for privacy information.

[This is one of the finalists in the 2025 review contest, written by an ACX reader who will remain anonymous until after voting is done. I'll be posting about one of these a week for several months. When you've read them all, I'll ask you to vote for a favorite, so remember which ones you liked] If you've been following this blog for long, you probably know at least a bit about pharmaceutical research. You might know a bit about the sort of subtle measures pharmaceutical companies take to influence doctors' prescribing habits, or how it takes billions of dollars on average to bring a new medication to market, or something about the perverse incentives which determine the FDA's standards for accepting or rejecting a new drug. You might have some idea what kinds of hoops a company has to jump through to conduct actual research which meets legal guidelines for patient safety and autonomy. You may be less familiar though, with how the sausage is actually made. How do pharmaceutical companies actually go through the process of testing a drug on human participants? I'm going to be focusing here on a research subject's view of what are known as Phase I clinical trials, the stage in which prospective drugs are tested for safety and tolerability. This is where researchers aim to answer questions like “Does this drug have any dangerous side effects?” “Through what pathways is it removed from a patient's body?” and “Can we actually give people enough of this drug that it's useful for anything?” This comes before the stage where researchers test how good a drug is at actually treating any sort of disease, when patients who're suffering from the target ailments are given the option receive it as an experimental treatment. In Phase I clinical trials, the participants are healthy volunteers who're participating in research for money. There are almost no cases in which volunteer participation is driven by motivations other than money, because the attitudes between research participants and clinicians overwhelmingly tend to be characterized by mutual guarded distrust. This distrust is baked into the process, both on a cultural level among the participants, and by the clinics' own incentives. All of what follows is drawn from my own experiences, and experiences that other participants in clinical pharmaceutical research have shared with me, because for reasons which should become clear over the course of this review, research which systematically explores the behaviors and motives of clinical research participants is generally not feasible to conduct. https://www.astralcodexten.com/p/your-review-participation-in-phase

Dr. Catherine Brown, State Epidemiologist and State Public Health Veterinarian at the Massachusetts Department of Public Health, discusses ASTHO's recent meeting with the Council of State and Territorial Epidemiologists (CSTE) and the importance of the One Health approach; a recent ASTHO blog article details the importance of preparing to ensure animals are accounted for during radiological incidents; Dr. Dave Chokshi, Chair of the Common Health Coalition, explains the changes made to FDA regulations ahead of respiratory vaccination season, and how the coalition can help public health leaders prepare; and ASTHO will hold its next succession planning webinar on September 18th, with a focus on laying the groundwork and incorporating data into planning efforts.  ASTHO Web Page: One Health Webinars ASTHO Blog: Planning for Animal Needs During a Radiological Incident Common Health Coalition ASTHO Webinar: Succession Planning Part 2 of 3: Laying the Groundwork  

News: ST6 NK mission @3:57 Israel carries out attack in Qatar targeting Hamas leaders @7:33 Russia invades Poland..? @10:07 Russian losses in Ukraine @11:20 Trump's Epstein letter denial just suffered another huge blow @14:16 SCOTUS allows immigration agents to resume 'roving patrols' in LA @21:21 Howard Lutnick's Investment Firm Tariff Conflict of Interest @26:53 Politics: Dr. Paul Offit has been blocked from advising FDA @28:36 RFK Jr.'s anti-vax campaign targets science @30:32 Florida AG response @33:33 Trump's response House Republicans keep NIH funding Trump wanted to cut @37:44 Religious Nonsense: Ken Paxton encourages students to recite Lord's Prayer @42:30 Moroccan Feminist @44:06 Nigerian blasphemy @45:59 Health/Medicine/Science: Trump administration agrees to restore federal websites @47:02 Tylenol has entered the chat @49:11 West Coast Health Alliance @53:49 Pseudoscience: Severe knee pain @54:47

In this episode we are diving into the surprisingly fascinating world of cerumen, the scientific name for earwax. We'll explore its protective role, why some people produce more than others, and what happens when it builds up too much. Plus, we'll introduce you to a safe, innovative technique that's changing the way we manage earwax buildup—no risky poking required. Sahil Diwan is the Co-Founder and CEO of SafKan Health, the company behind OtoSet® — the world's first automated ear-cleaning headphones that can clean earwax buildup in 30 seconds. He's on a mission to solve one of the most overlooked yet widespread health issues: earwax buildup, which affects 35M+ Americans and can lead to conductive hearing loss, tinnitus, and chronic discomfort — among other issues. A first-generation immigrant from India, Sahil's journey began with a deeply personal problem — his brother Aadil's lifelong struggle with earwax buildup. What started as a college dorm experiment with 3D-printed prototypes is today an FDA-cleared medical device used by clinics nationwide — making ear care more accessible and consumer-friendly than ever before. The company's flagship OtoSet was named among the Best Health Designs of 2023 by Fast Company, while videos of the device in action have racked up over 250M views online, proving just how urgent and universal this problem is. Tens of thousands of Americans have reported finding relief with OtoSet: hearing clearer, feeling cleaner, and reconnecting with the sounds they've been missing. Sahil is one of the youngest people ever to receive FDA 510(k) clearance for a medical device and has raised $13M in venture funding on his journey to reshape the future of ear care. Learning Points: • What exactly is earwax, and what is its purpose in the body? • When should someone see a doctor or specialist about their earwax? • How is OtoSet, the world's first automated ear-cleaning headphones, revolutionizing how to clean earwax buildup? Social Media: • https://www.instagram.com/tryotoset • https://x.com/tryotoset • https://www.facebook.com/tryotoset • https://otoset.com/

In this episode of Recycled Content, APR Technical Director Scott Trenor takes over hosting duties to explore the FDA's role in ensuring recycled plastics are safe for use in food packaging with guest Sean Fischer, an FDA Regulatory Review Scientist within the Division of Food Contact Substances. The two dive into the evaluation process, and critical need behind the FDA's No Objection Letters (NOL), an official statement from the FDA signaling that the agency has reviewed a recycling process and has no concerns about its ability to produce material suitable for food-contact use. The conversation also tackles common misconceptions, international alignment with Europe's EFSA, and how recyclers can better navigate regulatory pathways. Tune in to hear how recycled plastics move from curbside collection to safe, food-contact applications, and what it means for the future of circular packaging.

In this special episode, host Jeremy Schrand sits down with Jill Brinck, Executive Director of CancerFree KIDS, and Dr. Genevieve Kendall, a CancerFree KIDS grant recipient and pediatric cancer researcher at Baylor College of Medicine. Together, they explore the power of early-stage research funding, the challenges and breakthroughs in treating childhood cancers, and the inspiring mission behind CancerFree KIDS. Dr. Kendall shares insights into her lab's work on fusion-driven rhabdomyosarcoma and how innovative models like transgenic zebrafish are helping uncover new therapeutic targets. Whether you're a parent, a scientist, or someone passionate about making a difference, this episode offers a compelling look at how collaboration and curiosity are driving real change in pediatric oncology. Learn more - CancerFree KIDS home page Learn more about Dr Kendall's research - Kendall Lab | Nationwide Children's Hospital Learn more about CTI - CTI - CRO Specializing In Clinical Research And Consulting  02:03 Jill Brink shares her personal and professional journey that led her to become Executive Director of CancerFree KIDS.  04:02 Why funding early-stage, high-risk research is essential for pediatric cancer, highlighting the lack of profitability and federal support in this space. 05:46 Securing funding for early-stage research presents major challenges, including the need for collaboration between scientists and business leaders.  07:06 How CancerFree KIDS selects research projects, outlining the role of their Scientific Advisory Council and the grant scoring process. 09:26 Success stories driven by CancerFree KIDS funding, including early support for clinical trials and advancements in flash proton therapy. 11:22 Dr. Genevieve Kendall explains the nature of fusion-driven rhabdomyosarcoma and why its aggressive behavior and lack of targeted therapies make it difficult to treat. 13:51 How the CancerFree KIDS grant supported a new partnership and provided seed funding to test a promising research idea. 14:50 The significance of identifying HAS3 as a novel target and how it opens new possibilities for treating rhabdomyosarcoma. 16:35 Dr. Kendall describes the role of transgenic zebrafish in her research and how they help uncover therapeutic targets through comparative oncology. 19:33 Both guests share what excites them most about the future of pediatric cancer research, including innovations in CRISPR and immunotherapy. 22:32 How CancerFree KIDS measures the long-term impact of its grants, citing follow-up funding, startup companies, and FDA projects. 24:19 Jill highlights impactful partnerships and community initiatives, such as Jersey Mike's Day of Giving and the 100-Mile Challenge. 26:15 Details about the 100-Mile Challenge, including its structure and supporting events throughout September. 27:51 How CancerFree KIDS engages with families affected by cancer, ranging from support programs to events that honor children and their journeys. 29:51 The future direction of CancerFree KIDS, including expansion, collaboration, and advocacy efforts with the state of Ohio. 

HOW MUCH DO DENTAL IMPLANTS COST!? Download the FREE Guide to Dental Implants Here: ⁠https://bit.ly/4n03wZIWant to know if you may be eligible for Permanent Teeth in 24 Hours? Take the 60 Second Quiz Here: ⁠https://bit.ly/4nnCrzo▬▬▬▬▬▬▬▬ Contents of this video ▬▬▬▬▬▬▬▬▬▬Disclaimer: Nuvia Dental Implant Centers are locally owned and operated by licensed dental practitioners. These locally owned and operated practices are part of a professional network of dental implant centers operated by prosthodontists, oral surgeons, and restorative dentists. Each Nuvia Dental Implant Center has a business affiliation with Nuvia MSO, LLC, a Dental Support Organization that provides non-clinical support to each center.*Nuvia Dental Implant Centers are able to provide patients with a bridge made with an FDA approved permanent material, zirconia, in 24-hours. No temporary denture. Not all those who come in for a consultation are medically cleared to receive permanent zirconia teeth in 24-hours. Follow up appointments are required to confirm implant integration and make adjustments if necessary. Results may vary in individual cases. Patients represented in videos are actual NUVIA patient(s) and may have been compensated for their time in telling their story.*While soft foods immediately after surgery are generally approved by our clinical team, the local surgeon may give individual instruction on dental implant aftercare according to the specific circumstances applicable to each case.To hear patient's speech after prosthetic placement please search Nuvia Dental Implant Center on YouTube and watch patient stories. *Individual results may vary based on a number of factors.Copyright 2024. Nuvia Dental Implant Centers. All rights reserved.

Microsoft reportedly plans to begin using Anthropic's latest Claude models to power some of the Copilot features in its Office 365 apps. In a report published Tuesday, The Information said the tech giant would announce the change "in the coming weeks." Microsoft currently relies on OpenAI's tech to power the majority of AI features found inside of Word, Excel, Outlook and PowerPoint. Also, the FDA approved the biotech company eGenesis to begin human trials of pig-to-human kidney transplants. eGenesis provides pigs with CRISPR-modified genes. These genetic changes reduce the chances of organ rejection in human recipients. Learn more about your ad choices. Visit podcastchoices.com/adchoices

On today's Good Day Health Show - ON DEMAND…Host Doug Stephan and Dr. Ken Kronhaus of Lake Cardiology (352-735-1400) cover a number of topics affecting our health.First up, Doug and Dr. Ken discuss the biggest news stories in the medical world, starting with a focus on new findings on COVID-19 silently accelerating the aging of arteries with a sharp in crease for women, updated guidance from the FDA on updated COVID-19 vaccines, and why the CDC and FDA aren't seeing eye-to-eye.Then, a discussion on Omega-3s and the difference between Omega-3, Omega-6 and Omega-9.Next up, the latest AI algorithm in a trial helps match potential volunteers to relevant medical trials in an effort to speed up the enrollment process and accelerate the pace of research to make it easier and faster to match patients with the proper studies.Doug gives an update on his hearing troubles with his left ear after having a lady bug stuck in his ear. This revelation leads to a discussion on hearing aids and the connection between hearing problems and early dementia/Alzheimer's.Then, a new non-opioid pain killer that offers relief without the risk of addiction.Lastly, Doug and Dr. Ken address listener questions, including the link between passive smoking and the risk of getting COPD. Are you ready for this? It appears that a father's exposure to passive smoking as a child may impair the lifelong lung function of this children, increasing their risk of developing COPD. Let that sink in.Another question addressed — “What happens if we skip breakfast later in life?” Turns out, this could lead to a higher likelihood of developing osteoporosis. Website: GoodDayHealthrShow.com Social Media: @GoodDayNetworks

Vanessa is the manager of a reputable research foundation, a wife and mom of two.  She's also a convicted tri-state felon on multiple counts of identity theft and grand larceny.  She even spent time in jail. Only thing, her job, friends and much of her family have no idea.  What would happen if the truth came out?   HERS Visit forhers.com/SECRET for your personalized weight loss treatment options. Hers Weight Loss by Hers is not available everywhere. Compounded products are not approved or reviewed for safety, effectiveness, or quality by the FDA. Prescription required. See website for full details, important safety information, and restrictions. Actual price depends on product and plan purchased. HOME CHEF For a limited time, get 50% off and free shipping for your first box PLUS free dessert for life!  HomeChef.com/SECRET.  Must be an active subscriber to receive free dessert. MINT MOBILE Get this new customer offer and your 3-month Unlimited wireless plan for just $15 a month at  MINTMOBILE.com/SECRET. YOUTUBE You can now listen to The Secret Room on YouTube! THE SECRET ROOM | UNLOCKED Vanessa's childhood friend Jessica will join host Susie Lark to share her take on Vanessa's secret through the lens of a close friend. Host: Susie Lark. The Secret Room | Unlocked is yours when you support your favorite indie podcast that could with a membership at patreon.com/secretroom, Apple Podcasts or Spotify. There's a free trial! ALL OUR SPONSORS See all our sponsors past and present, and their offers, many of which are still valid: secretroompodcast.com/codes  FACEBOOK DISCUSSION GROUPThere's even more fun at The Secret Room Podcast Facebook Discussion Page!  Just ask to join, all are welcome. :) YOUR SECRET  Click "Share a Secret" at secretroompod.com! PODCAST TEAM Producers: Jessica Ruiz, Susie Lark. Story Development: Luna Patel. Music and Theme: Breakmaster Cylinder. LISTENER SURVEY Take our Listener Survey at SecretRoomPod.com!  

Many Americans struggle with the rising cost of healthcare. Analysts Terence Flynn and Erin Wright explain how AI might bend the cost curve, from Morgan Stanley's 23rd annual Global Healthcare Conference in New York.Read more insights from Morgan Stanley.----- Transcript -----Terence Flynn: Welcome to Thoughts on the Market. I'm Terence Flynn, Morgan Stanley's U.S. Biopharma Analyst.Erin Wright: And I'm Erin Wright, U.S. Healthcare Services Analyst.Terence Flynn: Thanks for joining us. We're actually in the midst of the second day of Morgan Stanley's annual Global Healthcare Conference, where we hosted over 400 companies. And there are a number of important themes that we discussed, including healthcare policy and capital allocation.Now, today on the show, we're going to discuss one of these themes, healthcare spending, which is one of the most pressing challenges facing the U.S. economy today.It is Tuesday, September 9th at 8am in New York.Imagine getting a bill for a routine doctor's visit and seeing a number that makes you do a double take. Maybe it's $300 for a quick checkup or thousands of dollars for a simple procedure.For many Americans, those moments of sticker shock aren't rare. They are the reality.Now with healthcare costs in the U.S. higher than many other peer countries on a percentage of GDP basis, it's no wonder that everyone – not just investors – is asking; not just, ‘Why is this happening?' But ‘How can we fix it?' And that's why we're talking about AI today. Could it be the breakthrough needed to help rein in those costs and reshape how care is delivered?Now I'm going to go over to you, Erin. Why is U.S. healthcare spending growing so rapidly compared to peer countries?Erin Wright: Clearly, the aging population in the U.S. and rising chronic disease burden here are clearly driving up demand for healthcare. We're seeing escalating demand across the senior population, for instance. It's coinciding with greater utilization of more sophisticated therapeutics and services. Overall, it's straining the healthcare system.We are seeing burnout in labor constraints at hospitals and broader health systems overall. Net-net, the U.S. spent 18 percent of GDP on healthcare in 2023, and that's compared to only 11 percent for peer countries. And it's projected to reach 25 to 30 percent of GDP by 2050. So, the costs are clearly escalating here.Terence Flynn: Thanks, Erin. That's a great way to frame the problem. Now, as we think about AI, where does that come in to help potentially bend the cost curve?Erin Wright: We think AI can drive meaningful efficiencies across healthcare delivery, with estimated savings of about [$]300 to [$]900 billion by 2050.So, the focus areas include here: staffing, supply chain, scheduling, adherence. These are where AI tools can really address some of these inefficiencies in care and ultimately drive health outcomes. There are implementation costs and risks for hospitals, but we do think the savings here can be substantial.Terence Flynn: Great. Well, let's unpack that a little bit more now. So, if you think about the biggest cost buckets in hospitals, where can AI help out?Erin Wright: The biggest cost bucket for a hospital today clearly is labor. It represents about half of spend for a hospital. AI can optimize staffing, reduce burnout with a new scribe and some of these scribe technologies that are out there, and more efficient healthcare record keeping. I mean, this can really help to drive meaningful cost savings.Just to add another discouraging data point for you, there's estimated to be a shortage of about 10,000 critical healthcare workers in 2028. So, AI can help to address that. AI tools can be used across administrative functions as well. That accounts for about 15 to 20 percent of spend for a hospital. So, we see substantial savings as well across drugs, supplies, lab testing, where AI can reduce waste and improve adherence overall.Terence Flynn: Great. Maybe we'll pivot over to the managed care and value-based care side now. How is AI being used in these verticals, Erin?Erin Wright: For a healthcare insurer – and they're facing many challenges right now as well – AI can help personalize care plans. And they can support better predictive analytics and ultimately help to optimize utilization trends. And it can also help to facilitate value-based care arrangements, which can ultimately drive better health outcomes and bend the cost curve. And ultimately that's the key theme that we're trying to focus on here.So, I'll turn it over to you, Terence, now. While hospitals and payers could see notable benefits from AI, the biopharma side of the equation is just as critical here. Especially when it comes to long-term cost containment. You've been closely tracking how AI is transforming drug development. What exactly are you seeing?Terence Flynn: Yeah, a number of key constituents are leaning in here on AI in a number of different ways. I'd say the most meaningful way that could help bend the cost curve is on R&D productivity. As many people probably know, it can take a very long time for a drug to reach the market anywhere from eight to 10 years. And if AI can be used to improve that cycle time or boost the probability of success, the probability of a drug reaching the market – that could have a meaningful benefit on costs. And so, we think AI has the potential to increase drug approvals by 10 to 40 percent. And if that happens, you can ultimately drive cost savings of anywhere from [$]100 billion to [$]600 billion by 2050.Erin Wright: Yeah, that sounds meaningful. How do you think additional drug approvals lead to meaningful cost savings in the healthcare system?Terence Flynn: Look, I mean, high level medicines at their best cure disease or prevent people from being admitted to a hospital or seeking care to doctor's office. Equally important medicines can get people out of the hospital quicker and back to contributing or participating in society. And there's data out there in the literature showing that new drugs can reduce hospital stays by anywhere from 11 to 16 percent.And so, if you think about keeping people out of hospitals or physician offices or reducing hospital stays, that really can result in meaningful savings. And that would be the result of more or better drugs reaching the market over the next decades.Erin Wright: And how is the FDA now supporting or even helping to endorse AI driven drug development?Terence Flynn: If companies are applying for more drug approvals here as a result of AI discovery capabilities without modernization, the FDA could actually become the bottleneck and limit the number of drugs approved each year.And so, in June, the agency rolled out an AI tool called Elsa that's looking to improve the drug review timelines. Now, Elsa has the potential to accelerate these timelines for new therapies. It can take anywhere from six to 10 months for the FDA to actually approve a drug. And so, these AI tools could potentially help decrease those timelines.Erin Wright: And are you actually seeing some of these biopharma companies actually investing in AI talent?Terence Flynn: Yes, definitely. I mean, AI related job postings in our sector have doubled since 2021. Companies are increasingly hiring across the board for a number of different, parts of their workflow, including discovery, which we just talked about. But also, clinical trials, marketing, regulatory – a whole host of different job descriptions.Erin Wright: So, whether it's optimizing hospital operations or accelerating drug discovery, AI is emerging as a powerful lever here – to bend the healthcare cost curve.Terence Flynn: Exactly. The challenge is adoption, but the potential is transformative. Erin, thanks so much for taking the time to talk with us.Erin Wright: Great speaking with you, Terence.Terence Flynn: And thanks everyone for listening. If you enjoy Thoughts on the Market, please leave us a review wherever you listen and share the podcast with a friend or colleague today.

Nurses Out Loud with Jodi O'Malley MSN, RN – Hospitals once bill $40–$45 per COVID shot while tying vaccination rates to funding and bonuses. Nurses face denied exemptions and pressure to comply. RFK Jr. ends CMS incentives, and the FDA rescinds EUAs, shifting power back to choice. This moment highlights how money, policy, and ethics collide, urging nurses to stand with moral courage...

In this packed, long-form episode, we cover everything from financial empowerment to societal trends and shocking current events: South Carolina's Future Scholar program: Curtis Loftus, State Treasurer, joins the show to discuss how this tax-advantaged 529 plan is helping families save for college, pay down student loans, and even roll over leftover funds into a Roth IRA. Personal testimonials show how consistent investing—even small amounts—can make a massive impact on reducing student debt. RFK Jr. and vaccine oversight: An in-depth look at the FDA investigation of child deaths linked to COVID vaccines reported in VAERS, the gold-standard vaccine monitoring system. The episode explains why RFK Jr. and Dr. Marty Makary's efforts have some politicians in a panic, and what it could mean for vaccine safety and transparency. Gallup poll on birth rates and happiness: New data reveals that conservatives are maintaining above-replacement birth rates, while liberal households are having fewer children. We explore the mental health divide, societal priorities, and why married women with children report being the happiest group in America. Advice on prioritizing family over a perfectly planned career is also shared. Crime and public safety: A discussion on the release of dangerous criminals in Charlotte, NC, and how these policies fit into a broader leftist strategy, with examples including repeat offenders and high-risk individuals being released with minimal oversight. This episode ties together financial literacy, public health, family planning, and societal trends—offering a lens on how personal choices, political ideology, and government policy intersect in modern America.

Have you been hearing the buzz about the new medication approved for the treatment of fibromyalgia? Fibromyalgia can come with a myriad of symptoms that make everyday life more difficult. With the limited pharmaceutical options available, the addition of another FDA-approved medication is a ray of hope. Tonmya™ is the first medication approved for fibromyalgia in over 15 years, promising a new option for those of us with fibromyalgia. Today, Tami is joined by Dr. Seth Lederman, one of the co-founders of the company that developed Tonmya™, to talk about the journey from idea to FDA approval and what it could mean for the fibromyalgia community. With decades of experience in rheumatology, immunology, and drug development, Dr. Lederman has been focused on helping people with fibromyalgia for much of his career. In this conversation, Tami and Dr. Lederman discuss his medical and research background, why he focused on fibromyalgia, advances in fibromyalgia research, the FDA approval process, why Tonmya™ targets non-restorative sleep and Dr. Harvey Moldofsky's influence, clinical trial design, dosing studies, and FDA requirements, outcomes measured in trials and the focus on pain reduction and sleep challenges, challenges in developing Tonmya™ including high placebo response and financial risks, how Tonmya™ differs from Flexeril, side effects of Tonmya™ and how it compares to other treatments, how quickly patients may see benefits, tolerability and safety considerations, when Tonmya™ will be available and how it will be distributed, how patients can access Tonmya™ and find more information, efforts to make Tonmya™ affordable, the need for advocacy and raising awareness, future steps for Tonmya™, what you need to know about the criticisms of early Tonmya™ studies, and more.         Note: This episode is not meant to be medical advice. Every person and every situation is unique. The information you learn in this episode should be shared and discussed with your own healthcare providers. To learn more about the resources mentioned in this episode, visit the show notes. For daily doses of hope, inspiration, and practical advice, join Tami on Facebook or Instagram. Need a good book to read? Download Tami's books for free. Ready to take back control of your life and health? Schedule a complimentary consultation with a Certified Fibromyalgia Coach®.

In this episode of Medicine: The Truth, Dr. Robert Pearl and Jeremy Corr dig into growing public distrust in the two government agencies charged with protecting Americans' health: the Centers ... The post MTT #98: Can patients and doctors still trust the CDC, FDA? appeared first on Fixing Healthcare.

Nurses Out Loud with Jodi O'Malley MSN, RN – Hospitals once bill $40–$45 per COVID shot while tying vaccination rates to funding and bonuses. Nurses face denied exemptions and pressure to comply. RFK Jr. ends CMS incentives, and the FDA rescinds EUAs, shifting power back to choice. This moment highlights how money, policy, and ethics collide, urging nurses to stand with moral courage...

On this episode of The Steve Gruber Show, Steve sits down with Dr. Steven Quay, MD, PhD, a world-renowned physician–scientist with more than 380 published papers, seven FDA-approved drugs, and over 12,000 research citations. Dr. Quay weighs in on the recent RFK Jr. hearing, the fierce debate over COVID-19 vaccine mandates, and what these developments mean for the future of American healthcare and individual freedom. With his deep background in oncology, virology, and infectious disease, Dr. Quay brings a scientific yet commonsense perspective to one of the most polarizing topics in America today.

In this episode of Food Safety Matters, we speak with Dr. Dutcher [38:31] about: The internal structure of the Food Products Inspectorate (FPI) within FDA's OII OII's role and responsibilities for inspecting human foods at FDA, including examples of frontline activities How the FPI is equipped to facilitate outbreak investigations and recalls Priority work plans assigned to FPI in 2025, and how this work will be accomplished In light of reduced funding for state inspectoral partners, how FPI can work with state public health agencies to ensure that priority inspections are carried out How OII is working to help restore confidence in the food supply among U.S. consumers New technologies and platforms being leveraged by OII to advance operations both internally and structurally, and how they are benefitting OII operations and functions. News and Resources News Leaked Second MAHA Report Emphasizes Food Industry Deregulation, Reliance on Voluntary Industry Action [4:10] CDC Slashes FoodNet Surveillance From Eight Foodborne Pathogens to Two [16:21] Trump-Appointed CDC Director Dr. Susan Monarez Fired After Clashes With Secretary Kennedy [23:00] Boar's Head to Reopen Facility Behind Fatal Listeria Outbreak While Other Plants Remain Insanitary USDA Taking Over Boar's Head Inspections From State Officials at Plant Responsible for Outbreak [31:37] FDA Adds Six Artificial Food Dyes to List of Chemicals Under Post-Market Review [35:27] Resources Partnership for Food Safety Education—National Food Safety Education Month We Want to Hear from You! Please send us your questions and suggestions to podcast@food-safety.com  

We discuss the May 16 FDA approval of the first blood test to diagnose Alzheimer disease. This landmark approval marks a significant shift in how Alzheimer disease is identified, moving away from more traditional methods or invasive methods. Our guests, Howard Fillit, the Alzheimer's Drug Discovery Foundation, and Anthony “Nino” Sireci, MD, MSc, Eli Lilly and Company, help us understand this “huge accomplishment" and how it may be able to transform the diagnostic landscape from one of nihilism to one of hope and early intervention.

This week's episode will be focusing on soft tissue sarcomas. We last recorded this topic in 2023, and well we have some new FDA approvals and updates since then.We will go over the important details on the diagnosis, subtypes and treatment of a few soft tissue sarcomas. These are RARE tumors encompassing 1% of all adult cancers and having multiple subtypes that range from noncancerous tumors such as desmoid tumors to aggressive cancers and everything in between. 

Health experts talk about the FDA's latest restrictions for the COVID-19 shot and call center operators discuss the 988 Suicide & Crisis Lifeline. The post COVID-19 Vaccine Guidelines And 3 Numbers To Call For Help, This West Virginia Morning appeared first on West Virginia Public Broadcasting.

SPONSOR: Reliefband - If you deal with nausea, Reliefband is a breakthrough you need to know about. It’s the original anti-nausea wristband that quickly relieves and effectively prevents nausea and vomiting, without the use of drugs or drowsy side effects. You simply wear it on your wrist, adjust the intensity depending on how you’re feeling, and within minutes, it starts working. The new Premier Plus model even includes a digital clock and smart skin-sensing technology to help preserve battery life. It’s FDA-cleared technology originally developed for hospital use. If you want to cure your nausea problem FAST, join the hundreds of thousands of people who are nausea-free with Reliefband. Right now, there’s an exclusive offer just for listeners of the Rick Burgess Show. If you go to https://www.Reliefband.com and use promo code “RICKB” you’ll receive 20% off, plus free shipping!SPONSOR: Share the Arrows - a live event with Blaze Media’s own Allie Beth Stuckey in Allen, Texas on October, 11th. It’s not just an event—it’s a powerful, faith-filled experience where women come together to be encouraged, equipped, and reminded of their purpose as wives, moms, and daughters of God. This year’s lineup is fantastic: Jinger Duggar Vuolo, Alisa Childers, Shawna Holman, Taylor Dukes, Katy Faust, and worship by the amazing Francesca Battistelli. It’s going to be a powerful weekend your wife won't want to miss. Tickets will go fast, so don’t wait, go to https://www.ShareTheArrows.com to grab your tickets now.SPONSOR: - BlazeTV - In a world full of noise, we need a stronghold for bold voices, free thinkers, and fearless commentary that helps make sense of the chaos. At BlazeTV, we’ve built a home for some of the strongest, smartest voices in conservative media—people who tell it like it is, ask the tough questions the mainstream won’t touch, and aren’t afraid to challenge the narrative. When you subscribe to BlazeTV, you’re not just watching content—you’re supporting a movement. You’re backing creators who think for themselves, speak boldly, and refuse to be silenced by Big Tech or corporate media. You’re supporting investigative journalism that exposes corruption and original documentaries that shine a light on the deep state. So, if you’re ready to keep winning, shop your values and make sure we don’t lose the ground we’ve gained — go to https://www.BlazeTV.com/RICK and subscribe today, and you’ll save 20 bucks right now off our annual plan. See omnystudio.com/listener for privacy information.

SPONSOR: Reliefband - If you deal with nausea, Reliefband is a breakthrough you need to know about. It’s the original anti-nausea wristband that quickly relieves and effectively prevents nausea and vomiting, without the use of drugs or drowsy side effects. You simply wear it on your wrist, adjust the intensity depending on how you’re feeling, and within minutes, it starts working. The new Premier Plus model even includes a digital clock and smart skin-sensing technology to help preserve battery life. It’s FDA-cleared technology originally developed for hospital use. If you want to cure your nausea problem FAST, join the hundreds of thousands of people who are nausea-free with Reliefband. Right now, there’s an exclusive offer just for listeners of the Rick Burgess Show. If you go to https://www.Reliefband.com and use promo code “RICKB” you’ll receive 20% off, plus free shipping!SPONSOR: Share the Arrows - a live event with Blaze Media’s own Allie Beth Stuckey in Allen, Texas on October, 11th. It’s not just an event—it’s a powerful, faith-filled experience where women come together to be encouraged, equipped, and reminded of their purpose as wives, moms, and daughters of God. This year’s lineup is fantastic: Jinger Duggar Vuolo, Alisa Childers, Shawna Holman, Taylor Dukes, Katy Faust, and worship by the amazing Francesca Battistelli. It’s going to be a powerful weekend your wife won't want to miss. Tickets will go fast, so don’t wait, go to https://www.ShareTheArrows.com to grab your tickets now.SPONSOR: - BlazeTV - In a world full of noise, we need a stronghold for bold voices, free thinkers, and fearless commentary that helps make sense of the chaos. At BlazeTV, we’ve built a home for some of the strongest, smartest voices in conservative media—people who tell it like it is, ask the tough questions the mainstream won’t touch, and aren’t afraid to challenge the narrative. When you subscribe to BlazeTV, you’re not just watching content—you’re supporting a movement. You’re backing creators who think for themselves, speak boldly, and refuse to be silenced by Big Tech or corporate media. You’re supporting investigative journalism that exposes corruption and original documentaries that shine a light on the deep state. So, if you’re ready to keep winning, shop your values and make sure we don’t lose the ground we’ve gained — go to https://www.BlazeTV.com/RICK and subscribe today, and you’ll save 20 bucks right now off our annual plan. See omnystudio.com/listener for privacy information.

Two-time Emmy and three-time NAACP Image Award-winning television Executive Producer Rushion McDonald interviewed Tracy Hudson. A celebrity skincare expert:

Two-time Emmy and three-time NAACP Image Award-winning television Executive Producer Rushion McDonald interviewed Tracy Hudson. A celebrity skincare expert:

With Mark Zuckerberg to the right of him and Bill Gates to his left, President Trump hosts a big tech dinner that triggers a MAGA meltdown. Why the bread breaking is likely not what MAGA thinks it is. Jake Tapper tries to "gotcha!" FDA commish Marty Makary but ends up looking the fool.  The White House puts out our Audio Of the Day - a breathtaking look at the effects of DC crime on one grandmother who says Trump has been the only one to care.

About this episode: The FDA and CDC are tightening eligibility requirements for COVID-19 vaccines this year, pushing effective treatments out of reach for millions of Americans including young children. In this episode: Dr. Fiona Havers, formerly a senior adviser on vaccine policy at the CDC, draws on recent hospitalization rates to identify who is most at risk for severe COVID-19 infection and in need of immunization for protection. Guest: Dr. Fiona Havers, MHS, is an infectious disease physician, a medical epidemiologist, and an expert on vaccine-preventable respiratory diseases and vaccine policy. She previously led the Respiratory Virus Hospitalization Surveillance Network Team at the CDC's National Center for Immunization and Respiratory Diseases. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Recent FDA, CDC changes to COVID vaccination guidelines lead to confusion—WBAL Covid-19 vaccine license change: 12 key questions answered—Your Local Epidemiologist Despite federal shift, state health officials encourage COVID vaccines for pregnant women—Stateline Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

In today's VETgirl online veterinary continuing education podcast, Dr. Ashlie Saffire, DAVBP (feline practice), discusses Felcyin-CA1 (sirolimus delayed-release tablets), an FDA conditionally approved treatment option to slow the progression of hypertrophic cardiomyopathy (HCM) in cats manufactured by PRN Pharmacal. HCM is known as the silent killer in cats! Tune in to find out if Felycin-CA1 is the right choice for your HCM patient!Sponsored By: PRN Pharmacal

Thank you for joining us for our 2nd Cabral HouseCall of the weekend!   I'm looking forward to sharing with you some of our community's questions that have come in over the past few weeks…   Raina: Hi Dr. Cabral! Hope you're feeling groovy and vibrant on this fine day! :) I recently had a baby.. I was planning for a home birth but things didn't go as planned. After 100+ hours of labor I went to the hospital and ended up with an emergency c section. My baby was taken to the NICU because of struggling to breathe - she had swallowed meconium which quickly came out and she was then breathing fine. While I was in recovery from surgery and she was in the NICU the med team gave her a vit K shot, despite the fact that i previously told them no injections. Now I'm trying to right their wrongs. Is there anything I can do to help her body after receiving the vit K shot? Also, how could I best support her body after a c section and not getting the benefits of a natural vaginal birth? Thanks!!!!!                                                                     Jennifer: Hi Dr. Cabral! I would like to get your thoughts on mesenteric panniculitis. I am a healthy 50 year-old female, currently IHP level 1 student. I had a CT abd/pelvis a few months back for a pretty bad GI virus. Scan showed enterocolitis however incidentally noted “mesenteric panniculitis, likely chronic”. I have read this (mesenteric panniculitis) can be autoimmune related and wanted to get your thoughts and any recommendations. By the way, I will be completing my first Dr. Cabral 21 day detox in 2 weeks and already feel great! Thank you so much for all you do!                                                 Jill: Dr. Cabral, I enjoy and learn so much from your podcast and appreciated learning about mammogram alternatives in episode 3049. Similarly, I'd love to find DEXA alternatives with no radiation and wanted to get your feedback on REMS (Radiofrequency Echographic Multi Spectrometry). This technology has no radiation and is made by the Echolight company in Italy. It is currently available through Precision bone imaging in CA and AZ and because the technology is portable was also available to book at my local OsteoStrong location in Las Vegas, NV. Additionally, can you give your feedback on the FDA cleared device called OsteoBoost?                                                                                       John: He doc. Just wondering if you read the book the one minute cure and if you did what did you think about it . Thanks keep up the amazing work                                                                                                                                                                   John: Hey doc . In one of your previous podcast you mention how good the sauna is to do post workout, I'd like to know iif that's only after an anaerobic workout or if it's good after an aerobic workout to . Thanks       Thank you for tuning into this weekend's Cabral HouseCalls and be sure to check back tomorrow for our Mindset & Motivation Monday show to get your week started off right! - - - Show Notes and Resources: StephenCabral.com/3502 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!